SFX by Ex Libris Inc.

Title:	Time course of the changes in prednisolone pharmacokinetics after co-administration or discontinuation of rifampin
Source:	European Journal of Clinical Pharmacology [0031-6970] Lee, K H yr:1993

Basic

Full text

Full text available via SpringerLINK Contemporary 1997-Present

Year:

Volume:

Issue:

Start Page:

Full text available via SpringerLink Historical Archives Biomedical and Life Sciences

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Ndanusa, B U. "The effect of single does of rifampicin on the pharmacokinetics of oral nifedipine." Journal of pharmaceutical and biomedical analysis (1997): 1571-1575.
description	2.	Reitman, M L. "Rifampin's acute inhibitory and chronic inductive drug interactions: experimental and model-based approaches to drug-drug interaction trial design." Clinical pharmacology & therapeutics 89.2 (2011): 234-42.
description	3.	Niemi, M. "Pharmacokinetic interactions with rifampicin : clinical relevance." Clinical pharmacokinetics 42.9: 819-850.
description	4.	Levine, M A. "Pharmacokinetic and pharmacodynamic interactions between nisoldipine and propranolol." Clinical pharmacology & therapeutics : CPT. 43.1: 39-48.
description	5.	Shitara, Y. "Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in the hepatic clearance and intestinal absorption." Biopharmaceutics & drug disposition 34.1 (2012): 45-78.
description	6.	Van der Heyden, S. "Influence of P-glycoprotein modulation on plasma concentrations and pharmacokinetics of orally administered prednisolone in dogs." American journal of veterinary research 73.6 (2012): 900-7.
description	7.	Krishna, G. "Effects of oral posaconazole on the pharmacokinetic properties of oral and intravenous midazolam: a phase I, randomized, open-label, crossover study in healthy volunteers." Clinical therapeutics 31.2 (2009): 286-298.
description	8.	Lipp, Hans-Peter P. "Antifungal agents--clinical pharmacokinetics and drug interactions." Mycoses 51.1 (2008): 7-18.
description	9.	Andreasen, Astrid-Helene H. "A comparative pharmacokinetic study in healthy volunteers of the effect of carbamazepine and oxcarbazepine on CYP3A4." Epilepsia 48.3 (2007): 490-496.
description	10.	Orszulak-Michalak, D. "Influence of midazolam on pharmacokinetic parameters of procainamide in rabbits." Polish journal of pharmacology 54.2 (2002): 151-6.
description	11.	Beth Gadkowski, L. "Pharmacokinetics of rifampicin." Clinical infectious diseases 44.4 (2007): 618-9.
description	12.	Zhou, S. "Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs." Clinical pharmacokinetics 44.3 (2005): 279-304.
description	13.	Shearer, M J J. "Vitamin K metabolism and nutriture." Blood reviews 6.2 (1992): 92-104.
description	14.	Koenen Anna, Markus n. "Steroid hormones specifically modify the activity of organic anion transporting polypeptides." European journal of pharmaceutical sciences 47.4 (2012): 774-80.
description	15.	Dickschen, K. "Physiologically Based Pharmacokinetic Modeling of Tamoxifen and its Metabolites in Women of Different CYP2D6 Phenotypes Provides New Insight into the Tamoxifen Mass Balance." Frontiers in Pharmacology 3 MAY (2012): 92-92.
description	16.	Karlgren, M. "In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug-Drug Interactions." Pharmaceutical research 29.2 (2012): 411-426.
description	17.	Greenblatt, M D J. "Ritonavir and dexamethasone induce expression of CYP3A and P-glycoprotein in rats." Xenobiotica 34.2 (2004): 133-150.
description	18.	McAllister, W A. "Rifampicin reduces effectiveness and bioavailability of prednisolone." British medical journal (Clinical research ed. 1981) 286.6369 (1983): 923-5.
description	19.	Ducatelle, R. "Expression of P-Glycoprotein in the Intestinal Epithelium of Dogs with Lymphoplasmacytic Enteritis." Journal of comparative pathology 145.2-3 (2011): 199-206.
description	20.	Croubels, S. "Pharmacokinetic and pharmacodynamic properties of orally administered valacyclovir in an equine herpesvirus type 1 infection experiment." Journal of veterinary pharmacology and therapeutics 32.SUPPL. 1 (2009): 70-71.